You are here
Products
IDH2 (Isocitrate Dehydrogenase 2) [MD68R]
Product group: | Primary |
Monoclonal/ Polyclonal: | Monoclonal |
Clone: | EP271 |
Host: | Rabbit |
Isotype: | IgG |
Application: | Immunohistochemistry (IHC) |
Application notes: | 50-200 |
Conjugation Type: | Unconjugated |
Reactivity: | Human |
General notes: | Localization: membrane. |
Buffer: | citrate pH6.0 or EDTA pH8.0 |
UNSPSC code: | 12352203 |
Isocitrate dehydrogenase [NADP], mitochondrial (IDH2) is a 452 amino acid enyzme belonging to the isocitrate and isopropylmalate dehydrogenases family and contains two nucleotide binding regions. IDH2 is involved in the reduction of NADP+ to NADPH and maintains mitochondrial glutathione levels. Studies suggest that IDH2 plays a role in intermediary metabolism and energy production. IDH2 also tightly associates with the pyruvate dehydrogenase complex. (Shipping Cost: €200.00)
MDR1/ABCB1/P-Glycoprotein [EP271]
The multidrug resistance protein 1 (MDR-1), also known as P-glycoprotein 1 (PgP), is a conserved plasma membrane protein that functions as an ATP-dependent efflux pump with broad specificity. MDR-1 expression is thought to cause cross-resistance to structurally unrelated anti-cancer drugs, which may decrease intracellular drug concentrations. MDR-1 is typically expressed primarily in regions that act as epithelial barriers or perform excretory function in the liver, kidney, gastrointestinal tract, and the blood-brain barrier. In tumors, MDR-1 is widely expressed in many human cancers, commonly found in colon cancer, renal cancer, hepatocellular carcinoma and hematopoietic malignancies.
Alternative names: